retatrutide bloating Weight Loss Results:Trial Data and FDA Status Retatrutide vs. Other Weight Loss
Description
Notably, at higher doses, weight loss appeared to be continuing at week 48 without a clear plateau
Tirzepatides dual GIP/GLP-1 mechanism has demonstrated superior weight-loss efficacy in both clinical trials and real-world studies, enabling stronger payer uptake and prescriber preference
The right approach is not fear, but careful use
Examples include semaglutide, liraglutide, and tirzepatide
doi: 10.1172/JCI25483
Results guide decisions about staying on compounded semaglutide, switching to tirzepatide, or trying dual-compound GLP-Squared therapy
